Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 3/20 | 0.46 |
| ▸ | RAB9A | P51151 | 3/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | DHODH | Q02127 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.41 |
| ▸ | EGFR | P00533 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.41 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7066341 | 0.92 | KDM4E (0.44) | ALDH1A1DHODHMAPTTSHR | |
| SCHEMBL3852129 | 0.90 | ALDH1A1 (0.45) | NPC1RAB9APKMALDH1A1DHODH | |
| SCHEMBL7072731 | 0.89 | S1PR1 (0.46) | TSHR | |
| SCHEMBL5046716 | 0.87 | DHODH (0.58) | RAB9AALDH1A1DHODHKMT2APOLB | |
| SCHEMBL395325 | 0.87 | DHODH (0.46) | NPC1RAB9APKMALDH1A1DHODH | |
| SCHEMBL3883132 | 0.86 | DHODH (0.44) | NPC1RAB9APKMALDH1A1DHODH | |
| SCHEMBL436620 | 0.86 | DHODH (0.44) | NPC1RAB9AALDH1A1DHODHKMT2A | |
| SCHEMBL846105 | 0.86 | MAPT (0.45) | ALDH1A1DHODHKMT2AMEN1LMNA | |
| SCHEMBL63413 | 0.85 | NPC1 (0.56) | NPC1RAB9APKMALDH1A1DHODH | |
| SCHEMBL7071412 | 0.84 | DHODH (0.65) | NPC1RAB9APKMALDH1A1DHODH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 302 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9402793-B2 | Use of UV-filters to stabilize resveratrol in topical cosmetic compositions | DSM IP ASSETS B.V. (NL) | 2016-08-02 | — | — | US | claimed |
| US-20150174045-A1 | LIGHT PROTECTING COMPOSITION WITH REDUCED TOTAL AMOUNT OF UV FILTER CONTAINING A POLYSILOXANE-BASED UV FILTER | DSM IP ASSETS B.V. (NL) | 2015-06-25 | — | — | US | claimed |
| US-20130324616-A1 | USE OF UV-FILTERS TO STABILIZE RESVERATROL IN TOPICAL COSMETIC COMPOSITIONS | DSM IP ASSETS B.V. (NL) | 2013-12-05 | — | — | US | claimed |
| US-20130315848-A1 | COSMETIC COMPOSITION FOR SKIN WHITENING COMPRISING RESVERATROL | DSM IP ASSETS B.V. (NL) | 2013-11-28 | — | — | US | claimed |
| EP-2642973-A1 | COSMETIC COMPOSITION FOR SKIN WHITENING COMPRISING RESVERATROL | DSM IP Assets B.V. (NL) | 2013-10-02 | — | — | EP | claimed |
| EP-2642972-A1 | USE OF UV-FILTERS TO STABILIZE RESVERATROL IN TOPICAL COSMETIC COMPOSITIONS | DSM IP Assets B.V. (NL) | 2013-10-02 | — | — | EP | claimed |
| WO-2012069363-A1 | USE OF UV-FILTERS TO STABILIZE RESVERATROL IN TOPICAL COSMETIC COMPOSITIONS | DSM IP ASSETS B.V. (NL) | 2012-05-31 | — | — | WO | claimed |
| WO-2012069362-A1 | COSMETIC COMPOSITION FOR SKIN WHITENING COMPRISING RESVERATROL | DSM IP ASSETS B.V. (NL) | 2012-05-31 | — | — | WO | claimed |
| WO-2004062635-A1 | COMPOSITIONS FOR SKIN LIGHTENING COMPRISING BIS-PANTOYL-CYSTAMINE | DSM IP ASSETS B.V. (NL) | 2004-07-29 | — | — | WO | claimed |
| US-20020131939-A1 | Hair protection compositions | ROCHE VITAMINS INC. | 2002-09-19 | — | — | US | claimed |
| EP-3709956-B1 | COSMETIC OR DERMATOLOGICAL COMPOSITIONS | DSM IP ASSETS BV (NL) | 2024-10-23 | — | — | EP | disclosed |
| US-20220160649-A1 | PHARMACEUTICAL COMPOSITION | DOBMEYER RITA (CH) | 2022-05-26 | — | — | US | disclosed |
| EP-3941449-A1 | PHARMACEUTICAL COMPOSITION | Dobmeyer, Rita (CH) | 2022-01-26 | — | — | EP | disclosed |
| US-11207256-B2 | Method for solubilizing poorly water-soluble cosmetic agents | ATHENION AG (CH) | 2021-12-28 | — | — | US | disclosed |
| EP-2032115-B1 | COMPOSITIONS BASED ON HYPERBRANCHED CONDENSATION POLYMERS AND NOVEL HYPERBRANCHED CONDENSATION POLYMERS | DSM IP ASSETS BV (NL) | 2021-07-21 | — | — | EP | disclosed |
| WO-2002055029-A2 | HAIR PROTECTION COMPOSITIONS | ROCHE VITAMINS AG (CH) | 2002-07-18 | — | — | WO | disclosed |
| US-6165451-A | Cosmetic light screening composition | ROCHE VITAMINS INC. (US) | 2000-12-26 | — | — | US | disclosed |
| EP-1025836-A1 | Cosmetic light screening composition | F. HOFFMANN-LA ROCHE AG (CH) | 2000-08-09 | — | — | EP | disclosed |
| US-6069170-A | 2-(4-ALKOXY-ANILINOMETHYLENE)-PROPANEDIOIC ACID DIESTER USED AS SUNSCREEN AGENT | ROCHE VITAMINS INC. (US) | 2000-05-30 | — | — | US | disclosed |
| EP-0895776-A2 | Cosmetic light-screening composition | F. HOFFMANN-LA ROCHE AG (CH) | 1999-02-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220160649-A1 | PHARMACEUTICAL COMPOSITION | FGF23, FGFR3, FGFR2 | NPC1 1242/4885RAB9A 1462/4885PKM 3494/4885 |
| US-20150174045-A1 | LIGHT PROTECTING COMPOSITION WITH REDUCED TOTAL AMOUNT OF UV FILTER CONTAINING A POLYSILOXANE-BASED UV FILTER | ERCC4, ERCC2, ERCC1 | NPC1 3188/4885RAB9A 2804/4885PKM 3016/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.